227 related articles for article (PubMed ID: 25402950)
41. CLU "in and out": looking for a link.
Pucci S; Mazzarelli P; Nucci C; Ricci F; Spagnoli LG
Adv Cancer Res; 2009; 105():93-113. PubMed ID: 19879425
[TBL] [Abstract][Full Text] [Related]
42. Differential effects of clusterin/apolipoprotein J on cellular growth and survival.
Trougakos IP; Lourda M; Agiostratidou G; Kletsas D; Gonos ES
Free Radic Biol Med; 2005 Feb; 38(4):436-49. PubMed ID: 15649646
[TBL] [Abstract][Full Text] [Related]
43. Intracellular processing of apolipoprotein J precursor to the mature heterodimer.
Burkey BF; deSilva HV; Harmony JA
J Lipid Res; 1991 Jun; 32(6):1039-48. PubMed ID: 1658176
[TBL] [Abstract][Full Text] [Related]
44. Clusterin over-expression modulates proapoptotic and antiproliferative effects of 1,25(OH)2D3 in prostate cancer cells in vitro.
Shannan B; Seifert M; Boothman DA; Tilgen W; Reichrath J
J Steroid Biochem Mol Biol; 2007 Mar; 103(3-5):721-5. PubMed ID: 17224269
[TBL] [Abstract][Full Text] [Related]
45. Apolipoprotein J/clusterin in human erythrocytes is involved in the molecular process of defected material disposal during vesiculation.
Antonelou MH; Kriebardis AG; Stamoulis KE; Trougakos IP; Papassideri IS
PLoS One; 2011; 6(10):e26033. PubMed ID: 22016805
[TBL] [Abstract][Full Text] [Related]
46. Secretory clusterin (sCLU) overexpression is associated with resistance to preoperative neoadjuvant chemotherapy in primary breast cancer.
Niu ZH; Wang Y; Chun B; Li CX; Wu L
Eur Rev Med Pharmacol Sci; 2013 May; 17(10):1337-44. PubMed ID: 23740447
[TBL] [Abstract][Full Text] [Related]
47. Clusterin in Alzheimer's Disease: Mechanisms, Genetics, and Lessons From Other Pathologies.
Foster EM; Dangla-Valls A; Lovestone S; Ribe EM; Buckley NJ
Front Neurosci; 2019; 13():164. PubMed ID: 30872998
[TBL] [Abstract][Full Text] [Related]
48. Challenge and promise: roles for clusterin in pathogenesis, progression and therapy of cancer.
Shannan B; Seifert M; Leskov K; Willis J; Boothman D; Tilgen W; Reichrath J
Cell Death Differ; 2006 Jan; 13(1):12-9. PubMed ID: 16179938
[TBL] [Abstract][Full Text] [Related]
49. Direct Interaction of Selenoprotein R with Clusterin and Its Possible Role in Alzheimer's Disease.
Chen P; Wang C; Ma X; Zhang Y; Liu Q; Qiu S; Liu Q; Tian J; Ni J
PLoS One; 2013; 8(6):e66384. PubMed ID: 23805218
[TBL] [Abstract][Full Text] [Related]
50. Single Nucleotide Polymorphism rs11136000 of CLU Gene (Clusterin, ApoJ) and the Risk of Late-Onset Alzheimer's Disease in a Central European Population.
Balcar VJ; Zeman T; Janout V; Janoutová J; Lochman J; Šerý O
Neurochem Res; 2021 Feb; 46(2):411-422. PubMed ID: 33206315
[TBL] [Abstract][Full Text] [Related]
51. Far-infrared radiation inhibits proliferation, migration, and angiogenesis of human umbilical vein endothelial cells by suppressing secretory clusterin levels.
Hwang S; Lee DH; Lee IK; Park YM; Jo I
Cancer Lett; 2014 Apr; 346(1):74-83. PubMed ID: 24334140
[TBL] [Abstract][Full Text] [Related]
52. Chapter 1: Introduction.
Bettuzzi S
Adv Cancer Res; 2009; 104():1-8. PubMed ID: 19878769
[TBL] [Abstract][Full Text] [Related]
53. The role of clusterin (CLU) in malignant transformation and drug resistance in breast carcinomas.
Redondo M; Tellez T; Roldan MJ
Adv Cancer Res; 2009; 105():21-43. PubMed ID: 19879421
[TBL] [Abstract][Full Text] [Related]
54. Identification of human plasma proteins as major clients for the extracellular chaperone clusterin.
Wyatt AR; Wilson MR
J Biol Chem; 2010 Feb; 285(6):3532-3539. PubMed ID: 19996109
[TBL] [Abstract][Full Text] [Related]
55. Regulation of the expression of CLU isoforms in endometrial proliferative diseases.
Fuzio P; Valletti A; Napoli A; Napoli G; Cormio G; Selvaggi L; Liuni S; Pesole G; Maiorano E; Perlino E
Int J Oncol; 2013 Jun; 42(6):1929-44. PubMed ID: 23589125
[TBL] [Abstract][Full Text] [Related]
56. Alterations in the post-translational modification and intracellular trafficking of clusterin in MCF-7 cells during apoptosis.
O'Sullivan J; Whyte L; Drake J; Tenniswood M
Cell Death Differ; 2003 Aug; 10(8):914-27. PubMed ID: 12867999
[TBL] [Abstract][Full Text] [Related]
57. eIF3f reduces tumor growth by directly interrupting clusterin with anti-apoptotic property in cancer cells.
Lee JY; Kim HJ; Rho SB; Lee SH
Oncotarget; 2016 Apr; 7(14):18541-57. PubMed ID: 26988917
[TBL] [Abstract][Full Text] [Related]
58. Secreted CLU is associated with the initiation of triple-negative breast cancer.
Zhang D; Sun B; Zhao X; Cui Y; Xu S; Dong X; Zhao J; Meng J; Jia X; Chi J
Cancer Biol Ther; 2012 Mar; 13(5):321-9. PubMed ID: 22310975
[TBL] [Abstract][Full Text] [Related]
59. Therapeutic Potential of the Molecular Chaperone and Matrix Metalloproteinase Inhibitor Clusterin for Dry Eye.
Fini ME; Jeong S; Wilson MR
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33374364
[TBL] [Abstract][Full Text] [Related]
60. Spatiotemporal expression patterns of clusterin in the mouse inner ear.
Lee S; Shin JO; Sagong B; Kim UK; Bok J
Cell Tissue Res; 2017 Oct; 370(1):89-97. PubMed ID: 28687930
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
